Peptides targeted at prostate cancer mutation according to research

First of all, it is necessary to highlight the fact that more than 7000 naturally occurring peptides have been gradually discovered since the last century. In the human body, these peptides perform many important roles as hormones, growth factors, neurotransmitters, ion channel ligands or anti-infective agents. Research peptides are simply those that are used in scientific research for the purpose of obtaining knowledge and the results of their action, especially for the development of future farmaceuticals. Interest in peptides has increased recently, especially from pharmaceutical research and development. These potent and selective signaling molecules, which bind to specific cell surface receptors in the body to trigger various intracellular effects, have been shown to be highly effective and relatively safe in therapeutic applications. They are generally very well tolerated by patients and participants in clinical trials. Their action is highly selective and effective, therefore this promising potential in the field of medical use is the driving force for new and new research, studies and experiments. The surge in demand for research peptides is therefore part of the path to the pharmaceuticals and therapeutics of the future and overall progress in the field. Research Peptides vs Medicines? The essential difference between approved medicines and research peptides is that research peptides are intended exclusively for scientific and research purposes and experiments "in vitro", which means "in glass", that is, outside the body. They are not yet approved as medicines that a doctor could prescribe to treat any disease. Hundreds of peptide therapeutics have already been investigated and evaluated in clinical trials. It is the research that many scientists around the world are doing that often uses research peptides in laboratories to study beyond traditional peptide design. The goal is to discover variants of peptides that could subsequently become pharmaceuticals. On the basis of peptides, about 60 pharmaceutical medicines have already reached the market, which have passed everything necessary for approval by the authorities. In the US, it is the Food and Drug Administration (FDA) that must approve the medicine. Examples include the prostate cancer treatment LupronTM or the type 2 diabetes treatment VictozaTM. Both of these medicines achieved large sales turnovers. Such approved drugs are not research peptides. Research peptides cannot be listed or prescribed as medicines. Although they show excellent and safe results and effects in studies, they must go through a rigorous process of clinical trials and subsequent FDA approval. They can be used for research and scientific purposes, as they could lead to very important new discoveries and the development of future drugs. However, until then, they cannot be prescribed or used for prevention by doctors. Research Peptides As a Basis For Future Medicines Due to the promising potential of peptides for medical applications, more and more intensive research, studies and experiments with peptides are needed in order to discover the pharmaceutical substances of the present and future. Therefore, the demand for research peptides is increasing intensively to support the progress in these new fields of research. In clinical studies, research peptides have demonstrated exceptional safety and tolerability by study participants, while maintaining high selectivity, efficacy, and predictable metabolism. Peptides therefore represent a huge opportunity for further therapeutic development. The large increase in obesity and type 2 diabetes, as well as cancer mortality, has made these two areas one of the main areas that drive research and development of peptide-based medicines. In North America, but not only there, metabolic diseases such as obesity and diabetes are a serious and growing problem. Similarly, the increase in deaths from oncological diseases leads to the search for alternatives to traditional chemotherapy. Both of these areas call for the development of peptide-based medicines and stimulate further research. However, peptide research has also expanded into other areas. For example, in the field of infectious diseases, inflammation or rare diseases, and it could also have potential in diagnosis and vaccination. Thus, research peptides serve as the basis for experiments and development in laboratories. Crucial research and studies take place there, focusing mainly on uncovering and proving the therapeutic potential of peptides for future medicines. They are therefore extremely important for the further development and possible effective future medicines that could be used in the treatment of serious diseases. WarningTHE GOODS OFFERED BY THE SELLER IS INTENDED FOR SCIENTIFIC AND DEVELOPMENT PURPOSES ONLY. The goods offered by the Seller include chemical substances that shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. References / Links Fosgerau, K., & Hoffmann, T. (2015). Peptide therapeutics: current status and future directions. Drug Discovery Today, 20(1), 122–128.DOI Otvos, L., & Wade, J. D. (2014). Current challenges in peptide-based drug discovery. Frontiers in Chemistry, 2, 62.DOI Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021). Trends in peptide drug discovery.Nature Reviews Drug Discovery, 20, 309–325. DOI Lau, J. L., & Dunn, M. K. (2018). Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry, 26(10), 2700–2707.DOI FDA – Drugs@FDA Database - https://www.accessdata.fda.gov/scripts/cder/daf/ Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013).The future of peptide-based drugs. Chemical Biology & Drug Design, 81(1), 136–147. DOI